BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Re-Accreditation Confirms High Quality, Ethical Research at Baylor Research Institute


5/11/2010 10:29:59 AM

DALLAS, May 11 /PRNewswire-USNewswire/ -- Officials announced recently that Baylor Research Institute (BRI), part of the Baylor Health Care System, was re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The re-accreditation certifies that BRI maintains efficient systems for monitoring research participant safety and embraces ethical standards higher than required by law in order to protect human participants participating in BRI research programs. Only 200 out of the thousands of human research protection programs in the U.S., Canada and abroad have earned this prestigious distinction.

"To address any risks in human research, Baylor has always implemented protection programs that exceed federal guidelines," explains Michael Ramsay, M.D., president of Baylor Research Institute. "This accreditation re-affirms for the public that Baylor Research Institute is a premiere resource in the DFW area for both leading health care and cutting-edge medical knowledge. We strongly believe it's our commitment to research that's both ethically and scientifically sound that enables us to stand out in our field."

The AAHRPP is an independent, non-profit organization dedicated to ensuring rigorous and thorough practices to protect human participants in research projects. It conducts on-site inspections and thorough reviews of policies and procedures.

"The 2009 inspection lasted three days," says Elizabeth Cothran, Director of the Office of Research Subject Protection at BRI, who coordinated the process. "It was an exhaustive process that involved more than 20 interviews with members of the Institutional Review Board and Institutional Review Board staff, as well as BRI researchers, research staff and administrative representatives."

In their report, AAHRPP highlighted a number of strengths at BRI:

  • Organizational commitment to ethical research
  • Strong leadership prioritizing medical ethics
  • Thorough oversight to enable early interventions for potential risks
  • Numerous educational programs to facilitate the union of strong ethics and research

In 2003, BRI was one of the first five programs to receive accreditation from theAAHRPP. In 2006, the Institute received its first three-year reaccreditation. Dr. Ramsay says that not only does the accreditation benefit research participants and enhance public trust, the government and various funding agencies look more favorably on accredited institutions.

Dallas-based Baylor Research Institute, an affiliate of Baylor Health Care System, promotes research that brings innovative treatments from the laboratory to the patient bedside. The Institute focuses on basic and translational science, clinical trials, health care effectiveness and quality of care research. Currently, investigators at Baylor are conducting 800 active research protocols spanning more than 20 medical specialties. Opened in 1996, Baylor Institute for Immunology Research, a component of BRI, focuses on developing new therapies to treat conditions that involve the immune system such as cancer, autoimmune diseases, infectious diseases and organ transplantation.

For more information about the Baylor Research Institute, visit www.BaylorHealth.com. For more information about BIIR, visit www.BIIR.org.

SOURCE Baylor Research Institute



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES